SPOTLIGHT -
FDA’s Breakthrough Therapy Designation
Three key questions dominate the agency’s Breakthrough Therapy Designation program since its 2012 launch.
Meeting Unmet Medical Needs: The Disparity Dilemma
The US drug regulatory system fails to address the country’s most urgent medical needs with the resources appropriate for the task. But change is possible.